to the different environmental fates of congeners with different solubilities, volatilities, and rates of degradation/metabolism. As a result, these mixtures change spatially and temporally into the environment and are very different from the technical mixtures originally released into the environment.
The complex nature of PCDD, PCDF, and PCB mixtures complicates the risk evaluation for humans, fish, and wildlife. For this purpose, the concept of toxic equivalency factors (TEFs) has been developed and introduced to facilitate risk assessment and regulatory control of exposure to these mixtures. To apply this TEF concept, a fundamental understanding of the mechanism of action is a prerequisite. At present, there is sufficient evidence available that there is a common mechanism for these compounds, involving binding to the aryl hydrocarbon (Ah) receptor as an initial step. When applying the TEF concept, the toxicity of these compounds relative to that of 2,3,7,8-TCDD is determined on the basis of available in vivo and in vitro data. However, it should also be understood that the TEF concept is based on a number of assumptions and has limitations. In this respect, the most basic assumption is that the combined effects of the different congeners are dose or concentration additive, and results ofmany studies support this assumption.
In the last decade, several different TEF schemes have been developed for PCDDs, PCDFs, and dioxinlike PCBs. Recognizing the need for a harmonized approach in setting internationally agreed upon TEFs, the European Centre of Environmental Health of the World Health Organization (ECEH-WHO) and the International Programme on Chemical Safety (IPCS) have initiated a program to derive TEFs for these compounds for assessing the impact of these compounds on human and environmental health.
At an initial WHO consultation on the derivation of TEFs for wildlife for dioxinlike compounds, held on 9-10 August 1996 in Bilthoven, The Netherlands, the question was addressed whether it is appropriate to use TEFs derived for the purpose of human risk assessment to estimate the risk for fish and wildlife species. The meeting concluded that there was a need to derive separate sets of TEFs for fish and wildlife, and recommended to combine this effort with a reevaluation and possible update of existing TEFs for human health risk assessment. In addition, it was recommended that the same TEFs for human health and wildlife should be used as much as possible.
For the (re)evaluation process, experimental data on the relative potencies (REPs) of PCDDs, PCDFs, and dioxinlike PCBs for mammalian, avian, and fish species have been collected by the Institute TEFs and TEQs are used for risk characterization and management purposes, e.g., to help prioritize areas of concern for deanup. However, in relation to the use of TEFs for abiotic compartments, the biological meaning of these values is obscure. This is caused by the fact that the assumed biological or toxicological effect is influenced by many physicochemical factors before the actual uptake of the compounds by the organism takes place. Nevertheless, TEQ values can be used as relative measures between different abiotic samples, e.g., sediment and soil, to prioritize remedial actions. In relation to the initial transport of these compounds from the abiotic to biotic compartment, it was recognized that congenerspecific biota-sediment accumulation factors (BSAFs) can be used to predict the concentrations in fish tissue, after which these can be converted to TEQs using TEFs. The TEFs presented in this paper apply only to AhR-mediated responses, and this concept assumes a model of dose additivity. In relation to this prerequisite, we decided that for PCDDs, PCDFs, and some planar PCBs there is sufficient evidence from both in vivo and in vitro studies supporting the dose or concentration-additivity model for Ah receptor-mediated responses. In addition, it should be emphasized that the TEF concept cannot be applied to 
Compilation of the Database
Since 1993, the data of all available mammalian, bird, and fish studies on relative toxicity of dioxinlike compounds that meet the criteria of inclusion in a TEF scheme (1) have been collected, and this information has been stored in a database at the Karolinska Institute in Stockholm (Sweden). These publications were analyzed and the data to be included in the database were selected using the following criteria:
I.At least one PCDD, PCDF, or PCB congener and a reference compound must be induded in the study. However, it is recognized that some end points such as liver enlargement and tumor promotion are affected by both dioxinlike and nondioxinlike halogenated aryl hydrocarbons (HAHs; e.g., mono-or di-ortho PCBs). In addition, several biological or toxic effects have been described for PCBs, for example, which are probably not related to an Ah receptormediated mechanism of action. Among others, these effects include a decrease in dopamine levels (2, 3) , alterations in retinoid and thyroid hormone levels (4, 5) , and binding to the estrogen receptor (6) . These effects show distinctly different structure-activity relationships for PCBs than those observed for Ah receptor binding involving multiple ortho chlorine substitution or hydroxylated metabolites. Based on the four criteria mentioned earlier, these effects, how biologically relevant they might be, are not covered in this TEF concept. For these compounds and their associated effects, a different approach for risk assessment is needed, which might possibly involve the development ofan alternative toxic equivalency concept.
Compounds included in the database are the 2,3,7,8-substituted PCDDs and PCDFs and those PCBs with established dioxinlike activity, especially the non-and mono-ortho PCBs. We agreed that there are a large number of other halogenated compounds that meet the criteria for inclusion in the TEF concept and could contribute to the total concentration ofTEQs in environmental samples. These include any or all of the following classes of polychlorinated compounds: naphthalenes, diphenyl ethers, diphenyl toluenes, phenoxy anisoles, biphenyl anisoles, xanthenes, xanthones, anthracenes, fluorenes, dihydroanthracenes, biphenyl methanes, phenylxylylethanes, dibenzothiophenes, quaterphenyls, quaterphenyl ethers, and biphenylenes. In addition to the chlorinated compounds, brominated and chloro/bromo-substituted analogues of PCDDs (PBDDs) and PCDFs (PBDFs) have been found in the environment (7) (8) (9) (10) and are known to induce CYPlA1 activity in vivo and in vitro (11) . PBDDs and PBDFs have also been shown to cause developmental toxicity, and REPs have been determined in mammals and fish (12) (13) (14) . However, it was decided that, at present, insufficient environmental and toxicological data are available to establish a TEF value for any of the above compounds.
Calculation of REPs
The following methods were used to derive REPs from the available data: * REPs were used as reported in each publication; if experimental data were also reported, these were used to calculate the REPs using one of the methods below. (18) with the NOAEL calculated from a mink laboratory reproductive study in which the diets were subject to complete chemical characterization (151) . These two independent analyses of the TEF approach, utilizing different effects data sets and the same set of international TEFs (1, 20) 
TEFs for Birds
Although many studies with young or adult birds have shown dioxinlike toxic and biochemical effects of TCDD and PCBs, these studies were not designed for REPs of compounds to be reliably derived (56) (57) (58) (59) (60) (61) (62) (63) . At present, TEFs for birds can only be derived from egg injection studies, studies with cultured avian hepatocytes, and studies with cultured thymus cells.
The end points mentioned above have been studied in a number of avian species. These species include domestic chicken, duck, domestic goose, turkey, pheasant, gull, common tern, double-crested cormorant, and American kestrel (64) (65) (66) (67) (68) . As with fish and mammals, Ah receptor-mediated CYPlA1 induction has been found in a large number of avian species, clearly indicating an Ah receptor responsiveness in this taxa. This justifies the inclusion of birds in the TEF concept. The induction of CYPlA1 in avian systems has been studied for most of the environmentally relevant PCDDs, PCDFs, and dioxinlike PCBs. However, the number of studies that could be used for this evaluation was limited. REPs for Tier 1 studies were not available for PCDDs and PCDFs, but for some PCBs, Tier 1 studies (in ovo lethality) were available. In general, REPs for ethoxyresorufin-O-deethylase (EROD) induction for dioxins, furans, and nonortho-PCBs in birds are in the same range as those reported from mammalian systems. The major exception is TCDF, which can be more potent than TCDD in hepatocyte cultures from several species of birds (65, 66, 69) .
Based on studies with chicken embryos, it has been concluded that birds can be highly responsive toward non-ortho PCBs, although much of the information available concerns induction of CYPlAI and not distinct toxic (118) New data support the original value (91, 96, 108) ; no revision is recommended. 0.0001 0.0001 2',3,4,4',5-PentaCB (123) No new data are available; no revision is recommended. 0.0001 0.0001 2,3,3',4,4',5-HexaCB Recent data from semichronic studies suggest that the old value is appropriate (109). Higher REPs measuring 0.0005 0.0005 (156) nonspecific end points, e.g., effects on thyroid hormones and body and thymus weight, were not included in the evaluation. Some concern was raised about identity and purity of test compounds in some studies; no revision is recommended. (66) .
However, some toxic end points, such as porphyrin accumulation in cultured avian hepatocytes, should be approached with caution because structure-activity relationships differ significantly from those of CYPIA induction (74) (75) (76) . Based on this information, it is unclear if porphyrin accumulation in birds is uniquely an Ah receptor-mediated effect. Therefore, it is unclear whether it should be included in the TEF concept. This case again stresses the importance to include only those end points in which the Ah receptor-mediated mechanism is shown to be involved and is the major determining factor.
Review of TEFs Approach for Deriving TEFs
For reevaluation of the existing mammalian TEFs for PCDDs, PCDFs, and PCBs, both previously reviewed and new data were examined. These included all congeners that have been selected before and also published data of multiple ortho-substituted PCBs (1, 11, 77, 78) . For prioritization, a rank order was followed as was suggested at an earlier WHO/IPCS TEF meeting (1). The TEFs for humans and mammals were primarily derived from in vivo toxicity data, which were given more weight than in vitro and/or quantitative structure-activity relationship (QSAR) data. In vivo toxicity data were prioritized according to the following ranking scheme: chronic > subchronic > subacute > acute. In the final TEF selection, different Ah receptor-specific end points were also ranked according to toxic > biochemical (e.g., enzyme induction) response. For revision of the existing mammalian TEFs, we agreed that if the available information was considered insufficient to warrant a change, the existing value would remain. The suggested TEFs for humans and mammals, including a short description, are given in Table 1. A tiered approach was followed in deriving TEFs for fish and birds. Following this approach, we noted that the number of bird and fish studies, which could be used for the derivation of a TEF, was often very limited when compared with mammalian data. For all congeners, the studies that were given the most weight were tier 1 studies, followed by tiers 2, 3, and 4. The tiers were as follows: In a chicken embryo egg injection study, this compound was found to be a poor inducer of EROD (119) At present no data are available for this compound in birds; a value of 0.01 is recommended based on similar homolog class REPs across taxa for the hexaCDFs and heptaCDFs. At present, no data are available for this compound in birds; a value of 0.01 is recommended based on similar homolog class REPs across taxa for the hexaCDFs and heptaCDFs.
At present, no in viva or in vitro data are available for this compound in birds; a value of 0.0001 was recommended based on data from mammalian studies.a
Studies with chickens and wild avian species reported in vitro and in ovo effects, with REPs ranging from <0.0003 to 0.15 depending on the species (66, 68, 69, 122, 123) . A value of 0.05 is recommended.
Egg injection studies have not been carried out with this compound. Two studies with chick embryo hepatocytes from several bird species indicate a wide range of REPs (0.001-0.5) of this compound to induce EROD relative to TCDD (66, 68) . As for most species, REPs were close to a value of 0.1, which is the recommended value.
A 24-hr study with chickens determined a REP of 0.07 (124); a value of 0.1 is recommended.
One study determined the LD50 in chicken embryos after injection of the compound into the egg, and a REP of 0.002 was reported (125, 126 of dioxinlike chemicals. These factors can indude alterations in absorption, tissue distribution, and metabolism between individual congeners. The importance of pharmacokinetic factors has been illustrated with studies using octaCDD in rodents. This compound initiated dioxinlike responses following subchronic exposure to rats, with an estimated relative potency of 0.01 based on hepatic levels correlated with the induction of CYPlAI (87) . However, earlier acute toxicity studies had suggested that octaCDD was essentially nontoxic, with a TEF value less than 0.000001. These subchronic studies also showed that octaCDD is extremely poorly absorbed and absorption from the gastro-intestinal tract decreased with increasing dose (143 (88, 131, (144) (145) (146) (147) (148) . In this respect, it should be noted that the structure-activity relationship for binding to the Ah receptor and to CYP1A2 are not identical (149) . As the level of CYP1A2 is increased, dioxinlike compounds redistribute from the adipose tissue back to the liver. Thus, depending on the species and dose level, the binding of an Ah receptor agonist to CYP1A2 can alter tissue distribution. As a result of this CYP1A2 binding, hepatic REPs for these compounds are lower than those based on intake because of disproportionately high liver concentrations. However, if other tissues are considered, e.g., skin and lung, the REP values would be higher because the tissue concentrations are lower than expected based on administered dose (81) . (151) (152) (153) . These toxicokinetic interactions are quantitatively limited, compound and dose dependent, and probably the result of multiple mechanisms involving, among others, de novo synthesis of both the Ah receptor and CYP1A2 (151) . To some extent, these toxicokinetic interactions could explain the nonadditive effects that were observed when combinations of dioxins and PCB 153 were used in rodent studies (95) . To what extent these toxicokinetic interactions are also relevant at low-level environmental exposure is still unknown.
The position and degree of halogenation determines the rate and extent of metabolism, which is the key determinant of excretion or bioaccumulation of these compounds (95, 154) . Full lateral halogenation at the 2,3,7,8-positions produces PCDDs and PCDFs that lack two adjacent unsubstituted carbon atoms. These congeners tend to be very resistant to metabolism, as these positions are also preferentially oxidized by the cytochrome P450 system, most likely by the CYPIA enzymes. Because of the stress on the furan ring, PCDFs are more susceptible to biochemical degradation than PCDDs. In addition, the positions adjacent to the oxygen bridge in the PCDF molecule (positions 4 and 6) are more sensitive to metabolic attack than those in the PCDD molecule (95) .
For PCBs the presence of two adjacent unsubstituted carbon atoms also facilitates the metabolic conversion to more polar metabolites. As with PCDFs and PCDDs, the cytochrome P450 IA enzyme(s) seems to play an important role in metabolism of (155) . This is based on a study with rats, marine mammals, and wild bird species in which it was observed that the metabolic degradation of PCB 77 correlated well with EROD activity. However, the same study indicated that for fish species this isoenzyme might be less effective in metabolizing these PCBs (156) . In addition, several other P450 isoenzymes, e.g., P450 2B and 3A, might be involved in the metabolism of PCBs that have an ortho-substitution pattern. With an increasing ortho chlorine substitution pattern, the induction of P450 2B1 and 2B2 isoenzymes increases significantly (155, 157) . Studies with PCB patterns and enzyme activities in wild mammals indicate that, at least in seals and polar bears, the involvement of CYP2B isoenzymes in metabolism of PCBs cannot be excluded (158, .
The role of metabolism can also be important when comparing acute and subchronic studies. In rodent studies using both 2,3,7,8-TCDF and TCDD, it was demonstrated that the REP of 2,3,7,8-TCDF for enzyme induction was almost equal to that of TCDD after acute exposure. However, when subchronic studies were done, 2,3,7,8-TCDF was much less potent than TCDD due to its rapid metabolism and lack of bioaccumulation (88) . A similar explanation was suggested when comparing the relative potencies for the induction of cleft palate in mice by 1,2,3,7,8-pentaCDF versus 2,3,4,7,8-pentaCDF (160) .
When comparing the brominated dioxins and dibenzofurans with the chorinated ones, it appears that at least some brominated compounds can be more resistant to metabolism than their corresponding chlorinated analogs (12) . Species differences in metabolism might also be one of the causes for the observed differential TEFs between fish, birds, and laboratory mammals. For For PCBs the situation is more complex, as structure-activity relationships are less well defined for metabolism and associated bioaccumulation. The degree of accumulation is strongly determined by the capability of the organism to metabolize the various PCB congeners (22, 162) . This can differ qualitatively as well as quantitatively between species. In general, it can be stated that fish are less capable of metabolizing PCBs than most birds and mammals. In spite of the complexity of the above processes, the lack of chlorine substitution on both the meta and para positions in the PCB molecule appears to facilitate the metabolism of these compounds in most higher vertebrate species (21, 156, 158, 163) . As a result of this "biofiltering" by metabolism at different levels in the foodchain, the qualitative PCB pattern in top predators shows some resemblance, which allows selection of PCB congeners of major concern for risk assessment (164) .
Qualitative and quantitative changes occur in PCDD, PCDF, and PCB patterns among different trophic levels and between the abiotic and biotic components of different ecosystems. This is especially confounded when attempts are made to perform risk and exposure assessments from a contaminated soil or sediment. It The most extensively used biological in vitro response studied so far is the induction of the CYPIAJ gene. CYPJAJ gene induction has been measured by monitoring changes in mRNA (165, 166) , protein levels (66, 167) , and/or enzyme activity [i.e., EROD or aryl hydrocarbon hydroxylase (AHH)] (168, 169) .
In addition, permanently transfected cells have also been established that contain CYPlA-regulated reporter genes. These cell lines contain a permanently incorporated reporter gene that is regulated by the mouse CYPlAl regulatory region (55,142, 170,171). These cell lines have a number of advantages over conventional enzyme induction assays such as 1) a sensitive and more easily measurable enzyme activity; 2) chemical inducers do not act as competitive inhibitors of the reporter gene; and 3) a larger number of available species-and tissue-specific assays.
Only two studies have compared endogenous EROD induction to reporter gene induction (55,172). The structureactivity relationship of the tested chemicals was comparable between wild-type and recombinant H4IIE cells. Dose-response relationships exhibited comparable dynamic ranges, and binary mixtures of TCDD, PCB 126, and PCB 77 did not depart from additivity in either cell line. In addition, PCB 153 significantly antagonized induction by Volume 106, Number 12, December 1998 * Environmental Health Perspectives TCDD and PCB 126 in both cell lines. The recombinant cell line was found to be generally more sensitive to PCDDs, PCDFs, and PCBs when compared to the wild-type cells (172) . Additionally, Richter et al. (55) recently reported that a recombinant trout cell line (RLT 2.0) could be used as an approximate predictor of responses in fish. However, the use of this assay was not advocated to develop REPs for ecological risk assessment since it was still plagued by the same drawbacks that limit the utility of other in vitro assays.
In vitro CYP1A induction has also been used to assess the level of dioxin equivalents (TEQs) in a number of environmental samples (69, (173) (174) (175) (176) (177) . In general, the TEF/TEQ approach using CYP1A induction accurately predicted dioxin equivalents within a complex mixture when compared to gas chromatography-mass spectrometry analysis or in vivo assessments, but may overestimate the TEQs when using other responses such as PFC (91) . The accuracy of this in vitro approach also depends on the composition of the sample. The presence of high amounts of Ah receptor agonists that are not covered by the TEF concept (e.g, polycyclic aromatic hydrocarbons) can result in a considerable overestimation of TEQs in environmental samples. Furthermore, these in vitro studies have shown that some responses (i.e., PFC, reporter gene, and AHH/EROD induction) and cell lines (H4ILE, recombinant reporter cells) are susceptible to nonadditive interactions. This is especially true if the complex mixture contains PCB congeners that are partial Ah receptor agonists (91, 142, 178, 179 (11, 129, 180) . In addition, structure-activity relationships have also been determined for effects that are not directly related to the Ah receptor and involve both parent compounds and their hydroxylated metabolites. These non-Ah receptor-mediated structure-activity relationships indude binding to transthyretin and thyroxin-binding globulin (6j181,182), binding to the estrogen receptor (183, 184) , and decrease in dopamine levels (2, 3) . Based on these studies it can be concluded that the structure-activity relationships of the latter effects deviate significantly from those observed for the Ah receptor-mediated effects. As only Ah receptor-mediated effects are considered in the present TEF concept, these structure-activity relationships will not further be considered in this evaluation (see criteria above).
Most biological systems are complex, and it is unlikely that only one or a few chemical properties will suffice to describe them. Thus, it is necessary to characterize these compounds with a multitude of physicochemical descriptors. Such a broad chemical characterization may capture the underlying, hidden factors that correlate with the response of interest. This information can then be used as the future base for the selection ofcongeners for biological testing (185) .
Within the TEF concept, the critical question is how to identify the physicochemical properties that determine if a compound can be expected to be dioxinlike or not. The planar structure of the PCDDs and the PCDFs is characteristic for high Ah receptor binding affinity. Furthermore, the 2,3,7,8-chlorine substitution pattern is of great importance as well. PCBs show a larger chemical variation due to the possible rotation of the two phenyl rings. The number of chlorine atoms in the ortho-position will, in this case, define the degree of dioxinlike properties. However, from a chemical point of view, it is difficult to define the point at which the compounds lose their dioxinlike properties. As a consequence of this, no single PCB congener can be identified as being structurally representative for the whole dass of compounds. Hence, a number of congeners must be investigated in order to indude the many facets of chemical structure within the PCB class ofchemicals. The use of multivariate chemical characterization (118) in combination with factorial design provides a tool by which small sets of structurally representative congeners can be selected. This tool can be used in the design of in vitro and in vivo experiments in order to introduce systematic structural variation in the congeners to be tested. In studies of complex environmental mixtures, indicator congeners can be selected from the structural variation found in such matrices as flue gases from incineration plants or Aroclor mixtures. The use of these systematic and balanced sets of congeners in the experimental protocol will provide increased knowledge of the biological behavior ofthe compounds studied.
Small sets of congeners, representative for the PCDDs, PCDFs, and PCBs, have been suggested (186, 187) . Twenty congeners were selected based only on their physicochemical properties and not on expected biological activity. As a first screening of possible dioxinlike effects, PCDFs and PCBs were tested in different in vitro systems using primary hepatocytes from different species as well as rat and fish hepatoma cell lines. Based on these results, QSARs have been established to define the correlation between chemical properties and a dioxinlike biochemical response. As can be seen in Table 4 , these studies predict that a large number of PCBs, and also PCDFs, exhibit dioxinlike activity measured as in vitro induction of CYPIA (1) activity.
The systematic selection approach makes it possible to make interpolations and predictions of not yet tested congeners. In this way, all congeners within the chemical range in which the selection of test congeners were made can be ranked according to expected dioxinlike activity and the congeners of special interest can be identified and investigated further. This method has so far mainly focused on CYPlAI induction, but could also be used in the screening of other dioxinlinked effects or other groups of halogenated aromatics, e.g., polychlorinated naphthalenes and polybrominated diphenylethers.
Based on the information presented in Table 4 about the predicted dioxinlike activity of PCBs, it should be noted that experimental data were used from in vitro experiments. Therefore, the structure-activity relationships determined with this multivariate characterization await further confirmation from in vivo experiments, including the role of pharmacokinetics, before these dioxinlike PCBs can be included in the TEF concept. (84, (188) (189) (190) . The non-ortho and monoortho PCBs also elicit Ah receptor-mediated responses. As a consequence, TEFs have been assigned to these PCBs (1, 11, 77) .
From a risk assessment point of view this was a logical decision, as most environmental matrices contain PCDDs, PCDFs, and PCBs. In fact, in some environmental samples, the overall contributions of PCBs to TEQs exceed that of the PCDDs and PCDFs (191) . When concentrations of TEQs in complex mixtures from environmental matrices were determined in vitro and compared to TEQs by using REPs from the same in vitro system, the results were generally within a factor of 2 (192) .
However, the inclusion of PCBs in the TEF concept also poses a problem due to the nonadditive effects, which have been observed in laboratory studies with mixtures containing PCDDs, PCDFs, and PCBs. Ah receptor antagonist activities of certain PCB congeners, induding the major environmental contaminant PCB 153, have been reported in several experimental systems. Recendy, these nonadditive interactions of PCB on dioxinlike effects have been reviewed (193) . In summary, the following antagonistic effects ofnondioxinlike PCBs were described: induction of EROD activity in chick embryo hepatocytes (194) , splenic PFC response to sheep erythrocytes in mice (195) , splenic PFC response to trinitrophenyl-lipopolysaccharide in mice (196) , serum IgM units in mice (91) , mouse fetal deft palate (110, 195) , and chick embryo malformations and edema and liver lesions (197) . The apparent antagonism by PCB 153 of the TCDD-induced immunosupression is due to the enhanced immune response induced by PCB 153 (198) . In addition, synergistic interactions have also been reported between PCBs and dioxins in the development of porphyria in rats (199) and mice (89) , the induction of CYPIAI (152, 178) and thyroid hormone levels and associated enzyme activities (200, 201) . These multiple nonadditive interactions between dioxinlike and nondioxinlike HAHs require further investigation to establish the extent to which they compromise the TEF concept.
Several reports have also questioned the relative contributions ofTEQs associated with dioxinlike compounds versus the substantial daily intakes of natural nonchlorinated Ah receptor agonists in cooked foods and vegetables (193, 202, 203) . The Ah receptor agonist and antagonist activities of indole-3-carbinol have been reported (204) (205) (206) . Perinatal exposure of pregnant rats to indole-3-carbinol resulted in reproductive abnormalities in male rat offspring, which were also elicited by TCDD in the same study. However, when comparing the effects caused by indole-3-carbinol or TCDD, both similar and different responses were observed (205) .
In contrast, a recent study with TCDD or indole-3-carbizole in rats did not find characteristic TCDD-like responses, e.g., hypophagia, body weight loss, and CYPlAI induction (207) . These results suggest that at least in some animal and cell models, the potential effects of the natural Ah receptor agonists could be significant. However, it has been suggested that the difference in pharmacokinetics between natural and halogenated Ah receptor agonists may decrease the potential impact of the natural agonists in in vivo situations. These possible differences between halogenated and natural Ah receptor agonists, such as indole-3-carbinol, in pharmacokinetics and toxicodynamics should be examined in more detail in in vivo experiments. In view of the nonadditive effects mentioned above, a question has been raised as to which effect would compromise the TEF concept more: antagonism or synergism.
From the available experimental data, it appears that antagonism is the most commonly reported nonadditive effect between individual dioxinlike compounds and complex mixtures (195, (208) (209) (210) (211) (212) . However, it should be noted that the occurrence of either antagonism or synergism is ratio and dose dependent. With respect to nonadditive effects between TCDD and PCB 153 on CYPlAI induction in rodents, it was observed that synergism prevailed at the lower dose levels, while antagonism dominated at higher dose levels (95) . Mechanistically, this antagonism can be explained by the fact that less potent congeners still have Ah receptor binding affinities and therefore are effective competitors for binding the site (195, 209) . This reduces the probability of the more toxic dioxinlike compounds to bind to the Ah receptor. However, the less active congeners do not bind with such a high affinity that they would effectively induce EROD activity or cause other Ah receptor-mediated adverse effects (11) . In this respect, some results of interactive studies with these compounds are equivocal. For instance, 3,3',4,4'-tetraCB and TCDD caused greater than additive induction of AHH activity in the liver of rainbow trout at doses calculated to produce 50% or less of the maximum response. However, in rainbow trout at greater doses, the same mixture was found less than additive (213) . In addition, PCB 153 had an antagonistic effect on the induction of EROD activity by TCDD (214) , but was found to be synergistic in another study (215) .
In conclusion, there has been much discussion about the possible interactions between and among individual congeners in complex technical mixtures and extracts of environmental matrices (216) . Based on receptor theory and the proposed mechanism of action of Ah receptor-active compounds, an additive model for the prediction of TCDD TEQs still seems most plausible in spite of the also observed nonadditive interactions. It is unlikely that the use of additivity in the TEF concept will result in a great deal of error in predicting the concentrations of TEQs due to synergism or antagonism.
Validation of the TEF Concept for Environmental Risk Assessments
A range of validation studies with fish and birds have examined the suitability of an additive model of toxicity for these compounds. These span from isobolographic studies of several pairs of Ah receptor agonists (and/or antagonists) to the testing of complex environmental mixtures found in the environment.
In rainbow trout and lake trout embryos, binary mixtures ofAh receptor agonists were tested following the isobolographic method (14, 50, 217) . These interactions on embryo lethality between congener pairs were, in general, found to be additive. However, for the combinations of TCDD and some nonortho PCBs, deviations from additivity that were dependent on the ratio ofthe congeners were also reported (49, 213, 218) . With respect to these nonadditive interactions, (14) .
When testing synthetic or complex environmental mixtures of chemicals in fish, additivity also appears to be the general case (219) . This was shown with a synthetic mixture of Ah agonists and non-Ah receptor compounds in rainbow trout early life stage mortality tests in which results simply followed an additive model (40). The additivity model has also been investigated in fish through the use of environmentally derived mixtures. One study used the organic extract made from lake trout, which was injected into eggs of hatchery-reared rainbow trout (220) and lake trout (221) . Additive toxicity of PCDDs, PCDFs, and planar PCBs to developing trout embryos was also evaluated through the direct injection of environmentally derived mixtures into newly fertilized eggs (220 The results from these studies showed again that the mixture of these compounds present in lake trout acted in an additive fashion when compared with experiments using single congeners (40). The additive model of toxicity is also supported by studies of embryotoxicity in birds. The toxicity of an environmentally derived mixture of chemicals, induding dioxinlike chemicals, was tested in chicken and found to be additive (222) .
Additionally, the TEF approach could also be validated by using TEF factors derived from experiments in chickens that were successfully used to predict the embryo lethality for double crested cormorant eggs (175, 223) . The TEF and TEQ approaches were also succesfully applied in a biological monitoring study with great blue herons and double crested cormorants (224, 225) . Thus, as with fish, the additivity in the TEF concept is also supported by studies with (wild) birds. Based on the use of more environmentally relevant species, it can be concluded that the type of interaction that is most prevalent among Ah receptor agonists and non-Ah receptor compounds is additivity. However, more studies to validate the additivity in fish and wildlife are required to better understand the limitations of the TEF and TEQ approachs. Yet, evidence from fish and bird studies indicates that the hazards of not using such an approach are greater than the uncertainties currently observed with the TEF/TEQ approaches.
Conclusions
Based on an extension of the existing database (1), TEFs We also reviewed a number of uncertainties that could compromise the TEF concept when used for risk assessment purposes. These uncertainties include nonadditive interactions, differences in shape of the dose-response curve, and species responsiveness. This was based on the proposed Ah receptor mechanism of action for PCDDs, PCDFs, and dioxinlike PCBs, but was also based on a number of combination studies with mammals, birds, and fish that predicted the measured TEQ adequately according to t.he dose additive model-._ Therefore, the prediction of TEQs according to the TEF model is considered to be plausible and to be the most feasible approach for risk assessment of HAHs with dioxinlike properties. In view of the available scientific evidence from studies with mixtures, it was concluded that it is unlikely for the use of this additive model to result in a great deal of error in predicting the concentrations of TCDD TEQs or responses at environmentally relevant levels due to nonadditive interactions.
A summary of the suggested WHO TEFs for PCDDs, PCDFs, and dioxinlike PCBs is shown in 
